Biocon Ltd. | BIOCON | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Net Income |
| 10,026 | 8,709 | 8,462 | 7,716 | 6,430 |
Cash flow Operating Act... |
| 11,546 | 12,831 | 11,597 | 11,766 | 18,525 |
Investments in PPE |
| -12,221 | -16,042 | -17,463 | -16,978 | -15,960 |
Cash flow Investing Act... |
| -7,138 | -15,589 | -36,247 | -16,991 | -142,818 |
Dividend Paid |
| 793 | 701 | 0 | 0 | 718 |
Cash flow Financing Act... |
| -2,417 | 3,876 | 25,640 | 2,421 | 130,487 |
Cash at beginning of period |
| 4,490 | 6,593 | 8,247 | 8,970 | 6,537 |
Cash at end of period |
| 6,593 | 8,247 | 8,970 | 6,537 | 12,948 |
Free Cash Flow |
| -675 | -3,211 | -5,866 | -5,212 | 2,565 |